Quality by design and failure mode and effects analysis applied to the development of electromedical technology: Preliminary results

Quality by design and failure mode and effects analysis applied to the development of electromedical technology: Preliminary results

Quality and risk management have evolved with the advancement of pharmaceutical and technological development in healthcare, allowing greater control of each biomedical device's manufacturing processes. Failure Mode and Effect Analysis (FMEA) has been widely used in healthcare to ensure the qua...

Full description

Bibliographic Details
Main Authors:	Maria Alexandra Matallana Castellanos, Elisabeth Costa Monteiro, Daniel R. Louzada
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	Measurement: Sensors
Subjects:	Electromedical technology Foreign body location FMEA Magnetic measurement QbD Quality
Online Access:	http://www.sciencedirect.com/science/article/pii/S266591742100266X

Similar Items

The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect
by: Cristina-Ioana Barbalata, et al.
Published: (2022-09-01)

A quality by design approach for the development of lyophilized liposomes with simvastatin
by: Alina Porfire, et al.
Published: (2017-11-01)

Brief Note on the Development of Biotechnology
by: Karl Bayer
Published: (2014-01-01)

Quality by Design Approach Using Multiple Linear and Logistic Regression Modeling Enables Microemulsion Scale Up
by: Michele Herneisey, et al.
Published: (2019-05-01)

Formulation Approaches for Improving the Dissolution Behavior and Bioavailability of Tolvaptan Using SMEDDS
by: Jong-Hwa Lee, et al.
Published: (2022-02-01)

AAPS Workshop: accelerating pharmaceutical development through predictive stability approaches, April 4–5, 2016
by: A. L. Freed, et al.
Published: (2017-09-01)

QbD-mediated RP-UPLC method development invoking an FMEA-based risk assessment to estimate nintedanib degradation products and their pathways
by: Balaji Jayagopal, et al.
Published: (2020-09-01)

A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy
by: Cristina Ioana Barbălată, et al.
Published: (2021-09-01)

Carotenoid containing cationic nanoparticles for effective therapy for suppressing oxidative stress: An intranasal approach
by: Namdev Dhas, et al.
Published: (2023-09-01)

Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach
by: D. Akila Devi, et al.
Published: (2023-02-01)

Employing QbD strategies to assess the impact of cell viability and density on the primary recovery of monoclonal antibodies
by: Ole Jacob Wohlenberg, et al.
Published: (2023-02-01)

Quality by design approach for development and validation of a RP-HPLC method for simultaneous estimation of xipamide and valsartan in human plasma
by: Mahmoud M. Sebaiy, et al.
Published: (2022-09-01)

Development and validation of RP-HPLC method for estimation of brexpiprazole in its bulk and tablet dosage form using Quality by Design approach
by: Amol S. Jagdale, et al.
Published: (2021-07-01)

Implementation of QbD strategies in the inoculum expansion of a mAb production process
by: Ole Jacob Böhl, et al.
Published: (2021-03-01)

Modeling-based Approach Towards Quality by Design for a Telescoped Process
by: This Zahnd, et al.
Published: (2024-03-01)

Process Optimization and DOE Application in the Synthesis of Rociletinib Intermediate
by: S. Kapić, et al.
Published: (2018-07-01)

Formulation-by-Design of Efinaconazole Spanlastic Nanovesicles for Transungual Delivery Using Statistical Risk Management and Multivariate Analytical Techniques
by: Rashed M. Almuqbil, et al.
Published: (2022-07-01)

Development of Metronidazole Loaded Chitosan Nanoparticles Using QbD Approach—A Novel and Potential Antibacterial Formulation
by: Nagaraja Sreeharsha, et al.
Published: (2020-09-01)

Quality by Design Approach for the Development of Liposome Carrying Ghrelin for Intranasal Administration
by: Cecília de Barros, et al.
Published: (2021-05-01)

Tablet Geometry Effect on the Drug Release Profile from a Hydrogel-Based Drug Delivery System
by: Seyed-Farid Mohseni-Motlagh, et al.
Published: (2023-07-01)

Analysis of the Influence of Process and Formulation Properties on the Drying Behavior of Pharmaceutical Granules in a Semi-Continuous Fluid Bed Drying System
by: Tuur Vandeputte, et al.
Published: (2023-04-01)

Support Vector Regression Approach to Predict the Design Space for the Extraction Process of Pueraria lobata
by: Yaqi Wang, et al.
Published: (2018-09-01)

Continuous Manufacturing of Solvent-Free Cyclodextrin Inclusion Complexes for Enhanced Drug Solubility via Hot-Melt Extrusion: A Quality by Design Approach
by: Siva Ram Munnangi, et al.
Published: (2023-08-01)

Advances in Twin-Screw Granulation Processing
by: Uttom Nandi, et al.
Published: (2021-04-01)

A Design of Experiment Approach to Optimize Spray-Dried Powders Containing <i>Pseudomonas aeruginosa</i><i>Podoviridae</i> and <i>Myoviridae</i> Bacteriophages
by: Emilie Tabare, et al.
Published: (2021-09-01)

Quality by design (QbD) approach in processing polymeric nanoparticles loading anticancer drugs by high pressure homogenizer
by: Govind Soni, et al.
Published: (2020-04-01)

Quality by design approach: Regulatory need
by: Jaiprakash N. Sangshetti, et al.
Published: (2017-05-01)

Toward QbD Process Understanding on DNA Vaccine Purification Using Design of Experiment
by: Lalintip Hocharoen, et al.
Published: (2021-05-01)

Quality by Design Approach in Liposomal Formulations: Robust Product Development
by: Walhan Alshaer, et al.
Published: (2022-12-01)

Quality by Design (QbD) and Design of Experiments (DOE) as a Strategy for Tuning Lipid Nanoparticle Formulations for RNA Delivery
by: Lidia Gurba-Bryśkiewicz, et al.
Published: (2023-10-01)

Integrated Process Model Applications Linking Bioprocess Development to Quality by Design Milestones
by: Christopher Taylor, et al.
Published: (2021-10-01)

Quality by design (Qbd) approach to develop stability indicating HPLC method for estimation of rutin in chitosan-sodium alginate nanoparticles
by: Surendran Vijayaraj, et al.
Published: (2021-04-01)

The Development of a Stable Peptide-Loaded Long-Acting Injection Formulation through a Comprehensive Understanding of Peptide Degradation Mechanisms: A QbD-Based Approach
by: Yingxin Xiong, et al.
Published: (2024-02-01)

Characterization and Validation of a New 3D Printing Ink for Reducing Therapeutic Gap in Pediatrics through Individualized Medicines
by: Eduardo Díaz-Torres, et al.
Published: (2023-06-01)

Anabolic Peptide-Enriched Stealth Nanoliposomes for Effective Anti-Osteoporotic Therapy
by: Sagar Salave, et al.
Published: (2022-11-01)

Industrial application of QbD and NIR chemometric models in quality improvement of immediate release tablets
by: Ahmed Ramadan, et al.
Published: (2021-06-01)

Analytical Method Development for 19 Alkyl Halides as Potential Genotoxic Impurities by Analytical Quality by Design
by: Kyoungmin Lee, et al.
Published: (2022-07-01)

Determination of Three Alkyl Camphorsulfonates as Potential Genotoxic Impurities Using GC-FID and GC-MS by Analytical QbD
by: Kyoungmin Lee, et al.
Published: (2022-09-01)

Comprehensive stability-indicating method development of Avanafil Phosphodiesterase type 5 inhibitor using advanced Quality-by-Design approach
by: Mital Patel, et al.
Published: (2020-07-01)

Implementation of QbD Approach to the Analytical Method Development and Validation for the Estimation of Metformin Hydrochloride in Tablet Dosage Forms by HPLC
by: Mousa Sha’at, et al.
Published: (2022-05-01)